Animal Health Giant Zoetis Reports Q4 Earnings Tomorrow
Key Metrics to Watch:
* Revenue: Expected to reach $2.32 billion, up 4.7% year-over-year
* Adjusted Earnings: Projected to be $1.34 per share
* Analyst Coverage: Generally consistent estimates over the past month
* Peer Performance: Pfizer (PFE) reported 21.9% revenue growth, while Bristol-Myers Squibb (BMS) posted a 7.5% increase
Market Sentiment:
* Pharmaceutical sector share prices have remained stable ahead of earnings
* Zoetis stock has gained 5.5% over the last month
* Average analyst price target for Zoetis is $208.60
Analyst Commentary:
* Zoetis has exceeded revenue expectations in recent quarters
* Some analysts believe the company is well-positioned to maintain its growth trajectory